Squamous cell carcinoma of the oropharynx

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:500478OMIM:275355C10.8
Who is this for?
Show terms as
41Active trials81Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Squamous cell carcinoma of the oropharynx (also called oropharyngeal squamous cell carcinoma, or OPSCC) is a type of cancer that starts in the oropharynx — the middle part of the throat. This includes the base of the tongue, the soft palate (the back part of the roof of the mouth), the tonsils, and the back wall of the throat. The cancer grows from flat, thin cells called squamous cells that line these surfaces. This cancer can cause a range of symptoms depending on where exactly it starts. Common signs include a persistent sore throat, difficulty swallowing, a lump in the neck, ear pain, and changes in the voice. Many people first notice a painless lump in the neck, which happens when cancer spreads to nearby lymph nodes. Because these symptoms can seem like everyday problems, the cancer is sometimes found at a later stage. There are two main causes of this cancer. One is long-term use of tobacco and alcohol. The other — and now the most common cause in many countries — is infection with human papillomavirus (HPV), especially HPV type 16. HPV-related oropharyngeal cancer tends to affect younger, non-smoking adults and generally responds better to treatment. Treatment usually involves surgery, radiation therapy, chemotherapy, or a combination of these. Newer targeted therapies and immunotherapy drugs are also being used. With modern treatment, many people — especially those with HPV-related disease — have good outcomes.

Key symptoms:

Persistent sore throat that does not go awayDifficulty or pain when swallowingA lump or swelling in the neckEar pain, especially on one sideChanges in voice or hoarsenessUnexplained weight lossA sore or ulcer in the back of the mouth or throat that does not healFeeling like something is stuck in the throatCoughing up bloodJaw pain or stiffnessBad breath that does not improveNumbness in the mouth or throat area

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

10 events
Jun 2026Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma

Sara Medek — PHASE2

TrialNOT YET RECRUITING
May 2026Lattice-Based Radiotherapy and Chemoimmunotherapy for Oropharyngeal Squamous Cell Carcinoma

NYU Langone Health — PHASE1, PHASE2

TrialNOT YET RECRUITING
Apr 2026SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer

UNICANCER — NA

TrialNOT YET RECRUITING
Jun 2025ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the Oropharynx

Indiana University — NA

TrialRECRUITING
Apr 2025Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery

Ryan Carey — PHASE1

TrialRECRUITING
Apr 2025The Minimalist Trial-2

Washington University School of Medicine — PHASE2

TrialRECRUITING
Apr 2025De-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE)

Royal North Shore Hospital — NA

TrialRECRUITING
Mar 2025Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers

NexImmune Inc. — PHASE1

TrialNOT YET RECRUITING
Jan 2025Phase II Clinical Trial of De-Intensified Therapy in Human Papilloma Virus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma

University of Vermont Medical Center — PHASE2

TrialNOT YET RECRUITING
Aug 2024Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal Cancer

BlueSky Immunotherapies GmbH — PHASE1

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Squamous cell carcinoma of the oropharynx.

20 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

20 recruitingView all trials with filters →
Phase 27 trials
Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer
Phase 2
Actively Recruiting
PI: Clint T Allen, M.D. (National Cancer Institute (NCI)) · Sites: Bethesda, Maryland · Age: 18120 yrs
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer
Phase 2
Active
PI: Robert Ferris (ECOG-ACRIN Cancer Research Group) · Sites: Birmingham, Alabama; Scottsdale, Arizona +56 more · Age: 1899 yrs
Biomarker-Driven Radiation Therapy Dose Reduction After Transoral Robotic Surgery for the Treatment of HPV-Positive Oropharyngeal Cancer
Phase 2
Active
PI: James E Bates, MD (Emory University Hospital/Winship Cancer Institute) · Sites: Atlanta, Georgia; Atlanta, Georgia +1 more · Age: 1899 yrs
Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer
Phase 2
Actively Recruiting
PI: Sujith Baliga (Ohio State University Comprehensive Cancer Center) · Sites: Columbus, Ohio · Age: 1899 yrs
Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer
Phase 2
Active
PI: Clifton Fuller, MD, PHD (M.D. Anderson Cancer Center) · Sites: Houston, Texas · Age: 1899 yrs
Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma
Phase 2
Actively Recruiting
PI: Danielle MacNeil, M.D. (London Regional Cancer Program, London Health Scie) · Sites: London, Ontario · Age: 1899 yrs
Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study
Phase 2
Actively Recruiting
PI: Jonathan D Schoenfeld, MD, MPH (Dana-Farber Cancer Institute) · Sites: Boston, Massachusetts; Boston, Massachusetts · Age: 2299 yrs
Other12 trials
Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus
Actively Recruiting
· Sites: Rome · Age: 1899 yrs
The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan
Actively Recruiting
PI: Pei-Jen Lou, MD, PhD (National Taiwan University Hospital) · Sites: Kaohsiung City; Kaohsiung City +5 more · Age: 2099 yrs
Post-treatment Surveillance in HPV+ Oropharyngeal SCC
Active
PI: Eleni M Rettig, MD (Brigham and Women's Hospital) · Sites: Boston, Massachusetts · Age: 1899 yrs
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
Actively Recruiting
PI: Eric Chen, MD (Chao Family Comprehensive Cancer Center) · Sites: Orange, California · Age: 1899 yrs
Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?
Active
PI: Christian von Buchwald, Professor, MD, DMSci (Department of Otorhinolaryngology, Head and Neck S) · Sites: Copenhagen · Age: 1899 yrs
Liposomal Bupivacaine and Transoral Robotic Surgery
Actively Recruiting
· Sites: Danville, Pennsylvania · Age: 1899 yrs
Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
Actively Recruiting
PI: Wendell Yarbrough, MD (UNC Chapel Hill) · Sites: Rochester, Minnesota; Chapel Hill, North Carolina +1 more · Age: 1899 yrs
Circulating Biomarkers in Oropharyngeal Cancers
Active
PI: Gisela Helenius (Örebro University, Sweden) · Sites: Örebro
Monitoring and Early Response Evaluation Using HPV DNA - A Study on Patients With HPV-positive Throat Cancer (MER-HPV)
Actively Recruiting
PI: Johanna Sjövall, MD,PhD (Dept. of clincial sciences, Lund University) · Sites: Lund, Skåne County · Age: 1899 yrs
A Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC)
Active
PI: Nancy Lee, MD (Memorial Sloan Kettering Cancer Center) · Sites: Basking Ridge, New Jersey; Middletown, New Jersey +5 more · Age: 4599 yrs
IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas
Actively Recruiting
· Sites: Villejuif, Val De Marne; Créteil +14 more · Age: 1899 yrs
Evaluation of Tongue Base MucOsectomy & Step sErial Sectioning
Active
· Sites: Birmingham · Age: 1699 yrs

Specialists

Showing 25 of 81View all specialists →
MP
Maura Gillison, MD, PhD
HOUSTON, TX
Specialist
PI on 1 active trial
RP
Randy Kimple, MD, PhD
MADISON, WI
Specialist
PI on 1 active trial
PN
Phuc Felix Nguyen-Tân
Specialist
1 Squamous cell carcinoma of the oropharynx publication
MG
Maura L Gillison
HOUSTON, TX
Specialist
1 Squamous cell carcinoma of the oropharynx publication
LL
Lee Landess
INDIANAPOLIS, IN
Specialist
2 Squamous cell carcinoma of the oropharynx publications
SS
Siddharth Sheth
OCEAN, NJ
Specialist
2 Squamous cell carcinoma of the oropharynx publications
KS
Krithika Suresh
LAKEWAY, TX
Specialist
1 Squamous cell carcinoma of the oropharynx publication
AL
Asim Lal
RALEIGH, NC
Specialist
3 Squamous cell carcinoma of the oropharynx publications
TH
Trevor G Hackman
CHAPEL HILL, NC
Specialist
2 Squamous cell carcinoma of the oropharynx publications
EM
Emily Morris
Specialist
1 Squamous cell carcinoma of the oropharynx publication
PH
Paul M Harari
MADISON, WI
Specialist
1 Squamous cell carcinoma of the oropharynx publication
LG
Laila A Gharzai
CHICAGO, IL
Specialist
1 Squamous cell carcinoma of the oropharynx publication
NI
Natalia Issaeva
Specialist
2 Squamous cell carcinoma of the oropharynx publications
WY
Wendell G Yarbrough
NEW HAVEN, CT
Specialist
2 Squamous cell carcinoma of the oropharynx publications
TS
Travis P Schrank
CHARLESTON, SC
Specialist
2 Squamous cell carcinoma of the oropharynx publications
NL
Nicholas Lenze
ANN ARBOR, MI
Specialist
3 Squamous cell carcinoma of the oropharynx publications
DR
David I Rosenthal
Specialist
1 Squamous cell carcinoma of the oropharynx publication
DM
Douglas Adkins, MD
ANN ARBOR, MI
Specialist
PI on 1 active trial
JB
Julie E Bauman
WASHINGTON, DC
Specialist
PI on 1 active trial5 Squamous cell carcinoma of the oropharynx publications
CM
Charalampos Floudas, M.D.
BETHESDA, MD
Specialist
PI on 6 active trials
RF
Renata Ferrarotto
HOUSTON, TX
Specialist
PI on 5 active trials4 Squamous cell carcinoma of the oropharynx publications
EM
Eric Chen, MD
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Squamous cell carcinoma of the oropharynx.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Squamous cell carcinoma of the oropharynxForum →

No community posts yet. Be the first to share your experience with Squamous cell carcinoma of the oropharynx.

Start the conversation →

Latest news about Squamous cell carcinoma of the oropharynx

Disease timeline:

New recruiting trial: ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the Oropharynx

A new clinical trial is recruiting patients for Squamous cell carcinoma of the oropharynx

New recruiting trial: Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery

A new clinical trial is recruiting patients for Squamous cell carcinoma of the oropharynx

New recruiting trial: IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas

A new clinical trial is recruiting patients for Squamous cell carcinoma of the oropharynx

New recruiting trial: Safety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell Carcinoma

A new clinical trial is recruiting patients for Squamous cell carcinoma of the oropharynx

New recruiting trial: Training Swallowing Initiation During Expiration

A new clinical trial is recruiting patients for Squamous cell carcinoma of the oropharynx

New recruiting trial: SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal Cancers

A new clinical trial is recruiting patients for Squamous cell carcinoma of the oropharynx

New recruiting trial: Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer

A new clinical trial is recruiting patients for Squamous cell carcinoma of the oropharynx

New recruiting trial: Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC

A new clinical trial is recruiting patients for Squamous cell carcinoma of the oropharynx

New recruiting trial: Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma

A new clinical trial is recruiting patients for Squamous cell carcinoma of the oropharynx

New recruiting trial: De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx

A new clinical trial is recruiting patients for Squamous cell carcinoma of the oropharynx

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Is my cancer HPV-positive or HPV-negative, and how does that affect my treatment and prognosis?,What stage is my cancer, and what does that mean for my treatment options?,What are the likely side effects of treatment, and how can we manage them?,Is there a clinical trial I might be eligible for, especially one looking at reducing treatment intensity?,Will I need a feeding tube during treatment, and how long might I need it?,What follow-up schedule do you recommend after treatment to check for recurrence?,Should my family members be concerned about their own cancer risk, and should they be screened?

Common questions about Squamous cell carcinoma of the oropharynx

What is Squamous cell carcinoma of the oropharynx?

Squamous cell carcinoma of the oropharynx (also called oropharyngeal squamous cell carcinoma, or OPSCC) is a type of cancer that starts in the oropharynx — the middle part of the throat. This includes the base of the tongue, the soft palate (the back part of the roof of the mouth), the tonsils, and the back wall of the throat. The cancer grows from flat, thin cells called squamous cells that line these surfaces. This cancer can cause a range of symptoms depending on where exactly it starts. Common signs include a persistent sore throat, difficulty swallowing, a lump in the neck, ear pain, and

How is Squamous cell carcinoma of the oropharynx inherited?

Squamous cell carcinoma of the oropharynx follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Squamous cell carcinoma of the oropharynx typically begin?

Typical onset of Squamous cell carcinoma of the oropharynx is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Squamous cell carcinoma of the oropharynx?

Yes — 20 recruiting clinical trials are currently listed for Squamous cell carcinoma of the oropharynx on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Squamous cell carcinoma of the oropharynx?

25 specialists and care centers treating Squamous cell carcinoma of the oropharynx are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.